Open Farm removes six dog food lots over plastic film issue

Open Farm has pulled six limited lots of dog food from distribution after identifying small pieces of food-grade plastic film in some products, in what outside reports describe as a market removal rather than a recall. The company said the material is non-toxic and does not present a health risk to dogs, and it instructed distributors to destroy affected inventory and retailers to remove it from sale. Pet parents were offered refunds or replacements. (dogfoodadvisor.com)

The episode appears to center on a manufacturing defect, not a pathogen, toxin, or nutrient imbalance. According to Dog Food Advisor, the source was liner material from raw protein ingredients that was not fully removed before production. That framing is important because foreign-material events in pet food often raise immediate concern among pet parents and veterinary teams, but the available reporting here points to a contained quality-control failure with limited lots rather than a broader food-safety emergency. (dogfoodadvisor.com)

Regulatory terminology also shapes how this story should be understood. FDA says a market withdrawal is a firm's removal or correction of a distributed product involving a minor violation, or no violation, that would not ordinarily lead to agency legal action. Truth About Pet Food, citing FDA enforcement-report records, characterized Open Farm's action as a withdrawal tied to “foreign object (plastic)” contamination. As of the sources reviewed here, the most accessible public reporting has come from trade and consumer watchdog outlets rather than a prominent FDA recall announcement page, which is consistent with the lower-risk posture described in those reports. (fda.gov)

Open Farm's broader brand positioning may also shape industry reaction. The company has built a reputation around ingredient traceability, sustainability, and premium sourcing, including public-facing transparency tools for consumers. That makes even a low-risk packaging or ingredient-handling lapse notable, because it tests how well premium brands translate sourcing claims into manufacturing controls and incident communication. In this case, the company reportedly implemented corrective actions and directed the trade to remove affected product promptly. (openfarmpet.com)

Independent expert commentary on this specific event was limited in the available public record. Still, the pattern is familiar to veterinarians: foreign-material incidents can generate anxiety out of proportion to toxicologic risk, especially when the contaminant is visible and the brand has a strong direct-to-consumer following. In practical terms, clinics may be asked whether ingestion of small, non-toxic plastic fragments warrants emergency care. Based on the available reporting, the more likely concerns would be mild oral irritation, vomiting, or gastrointestinal upset if fragments were consumed, rather than systemic toxicity. That is an inference from the nature of the material and the company's description, not a published clinical case series. (dogfoodadvisor.com)

Why it matters: For veterinary professionals, this is less about treating poisoned patients and more about triage, communication, and trust. Teams may need a clear script for pet parents: confirm whether the product is one of the affected lots, advise discontinuation if it is, assess for signs consistent with foreign-body irritation or GI upset, and document any suspected adverse events. The case also underscores the value of distinguishing among recalls, withdrawals, and market removals when counseling clients, because those terms carry different implications for risk, regulatory oversight, and urgency. (fda.gov)

There is also a supply-chain lesson here. The reported root cause, liner material from raw protein ingredients entering production, points to a failure in ingredient receiving or preprocessing controls. For clinics and hospital buyers that stock or recommend over-the-counter diets, incidents like this can inform conversations about manufacturing oversight, supplier verification, and how brands communicate corrective actions when quality issues surface. (dogfoodadvisor.com)

What to watch: The next signal will be whether FDA’s enforcement-report system adds or updates an entry with classification details, whether Open Farm publishes a fuller public notice with product names and lot codes, and whether any veterinary toxicologists or nutrition specialists weigh in publicly on expected clinical risk. For now, the story looks like a contained foreign-material market removal with low expected medical impact, but one that still matters because pet parents often turn first to veterinary teams for interpretation. (fda.gov)